28/02/2014
Results of RUTI®‘s Phase II clinical trial, published in Plos One
The prestigious magazine Plos One has just published the article "Safety, Tolerability, and Immunogenicity of…
Read More
15/01/2012
Archivel secures funding to bring the anti-tuberculosis therapeutic vaccine RUTI® to market
TGT, an industrial group from Barcelona, Spain, has facilitated the exit of the financial investor…
Read More
Archivel on the media
TV3, QuèQuiCom
2016
